Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery-Reference-Cited by-同舟云学术

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery

Published:2022-05-22 Issue:14 Volume:11 Page:2755-2766
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Yang Yilan¹²³^ORCID,Zhao Xu¹²³,Wang Xuanyi¹²³,Jin Kairui¹²³^ORCID,Luo Jurui¹²³,Yang Zhaozhi¹²³,Mei Xin¹²³,Ma Jinli¹²³,Shao Zhimin²⁴,Zhang Zhen¹²³,Chen Xingxing¹²³,Guo Xiaomao¹²³^ORCID,Yu Xiaoli¹²³^ORCID

Affiliation:

1. Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai China

2. Department of Oncology, Shanghai Medical College Fudan University Shanghai China

3. Shanghai Key Laboratory of Radiation Oncology Shanghai China

4. Department of Breast Surgery Fudan University Shanghai Cancer Center Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4651

Reference32 articles.

1. Ductal Carcinoma In Situ: Terminology, Classification, and Natural History

2. Breast cancer statistics, 2019

3. Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion

4. Cancer Statistics, 2021

5. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical significance of HER2 expression in DCIS;Medical Oncology;2022-11-09